• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多平台代谢组学揭示早期食管鳞状细胞癌的可能生物标志物。

A multi-platform metabolomics reveals possible biomarkers for the early-stage esophageal squamous cell carcinoma.

机构信息

Department of Nutrition and Food Hygiene, Public Health College, Harbin Medical University, Harbin, PR China.

The Affiliated Tumor Hospital of Harbin Medical University, Harbin Medical University, Harbin, PR China.

出版信息

Anal Chim Acta. 2022 Aug 8;1220:340038. doi: 10.1016/j.aca.2022.340038. Epub 2022 Jun 8.

DOI:10.1016/j.aca.2022.340038
PMID:35868700
Abstract

BACKGROUND

Esophageal squamous cell carcinoma (ESCC) is one of the most prevalent types of upper gastrointestinal malignancies. This work aimed to identify potential biomarkers for early screening for ESCC and characterize the systemic metabolic disturbances underlying ESCC using multi-platform metabolomics analysis.

METHODS

We divided 239 patients (the early-stage ESCC patients, n = 132; Healthy controls, n = 107) into discovery and validation sets after matching age and sex. Integrated statistical and multi-platform serum metabolomics analyses were used to screen and validate significant metabolites linked to ESCC patients.

RESULTS

Multi-platform metabolomics analyses showed that amino acid and lipid metabolism were crucial in the etiology of ESCC. Five metabolites, tryptophan (Trp), citrulline, l-carnitine, lysine, and acetyl-carnitine, were selected as potential biomarkers to establish a diagnosis panel, which showed high accuracy in distinguishing ESCC patients from healthy controls (area under the receiver operating characteristic curve, 0.873, 95% confidence interval [CI]: 0.825-0.925).

CONCLUSIONS

This work laid the groundwork for understanding the etiology of ESCC. The diagnostic panel showed potential usefulness in early-stage ESCC diagnosis in clinical practice.

摘要

背景

食管鳞状细胞癌(ESCC)是最常见的上消化道恶性肿瘤之一。本研究旨在通过多组学代谢组学分析,鉴定 ESCC 早期筛查的潜在生物标志物,并阐明 ESCC 潜在的系统性代谢紊乱。

方法

我们将 239 名患者(早期 ESCC 患者,n=132;健康对照,n=107)按照年龄和性别进行匹配,分为发现和验证组。我们采用整合的统计和多组学血清代谢组学分析方法,筛选和验证与 ESCC 患者相关的显著代谢物。

结果

多组学代谢组学分析表明,氨基酸和脂质代谢在 ESCC 的发病机制中起关键作用。选择 5 种代谢物(色氨酸(Trp)、瓜氨酸、左旋肉碱、赖氨酸和乙酰肉碱)作为潜在的生物标志物来建立诊断模型,该模型在区分 ESCC 患者和健康对照方面具有较高的准确性(受试者工作特征曲线下面积,0.873,95%置信区间[CI]:0.825-0.925)。

结论

本研究为了解 ESCC 的发病机制奠定了基础。该诊断模型在临床实践中对早期 ESCC 诊断具有潜在的应用价值。

相似文献

1
A multi-platform metabolomics reveals possible biomarkers for the early-stage esophageal squamous cell carcinoma.多平台代谢组学揭示早期食管鳞状细胞癌的可能生物标志物。
Anal Chim Acta. 2022 Aug 8;1220:340038. doi: 10.1016/j.aca.2022.340038. Epub 2022 Jun 8.
2
Combining fecal microbiome and metabolomics reveals diagnostic biomarkers for esophageal squamous cell carcinoma.联合粪便微生物组和代谢组学揭示食管鳞癌的诊断生物标志物。
Microbiol Spectr. 2024 May 2;12(5):e0401223. doi: 10.1128/spectrum.04012-23. Epub 2024 Mar 18.
3
Global and targeted metabolomics of esophageal squamous cell carcinoma discovers potential diagnostic and therapeutic biomarkers.食管鳞癌的全球靶向代谢组学研究发现潜在的诊断和治疗生物标志物。
Mol Cell Proteomics. 2013 May;12(5):1306-18. doi: 10.1074/mcp.M112.022830. Epub 2013 Feb 8.
4
Towards Tyrosine Metabolism in Esophageal Squamous Cell Carcinoma.食管癌中酪氨酸代谢研究
Comb Chem High Throughput Screen. 2017;20(2):133-139. doi: 10.2174/1386207319666161220115409.
5
Untargeted metabolomics analysis of esophageal squamous cell cancer progression.食管鳞癌演进的非靶向代谢组学分析。
J Transl Med. 2022 Mar 14;20(1):127. doi: 10.1186/s12967-022-03311-z.
6
Disturbed tryptophan metabolism correlating to progression and metastasis of esophageal squamous cell carcinoma.色氨酸代谢紊乱与食管鳞状细胞癌的进展和转移相关。
Biochem Biophys Res Commun. 2017 May 6;486(3):781-787. doi: 10.1016/j.bbrc.2017.03.120. Epub 2017 Mar 23.
7
Global metabolomics reveals potential urinary biomarkers of esophageal squamous cell carcinoma for diagnosis and staging.全球代谢组学揭示了用于食管癌诊断和分期的潜在尿液生物标志物。
Sci Rep. 2016 Oct 11;6:35010. doi: 10.1038/srep35010.
8
Untargeted serum metabolomics reveals potential biomarkers and metabolic pathways associated with the progression of gastroesophageal cancer.非靶向血清代谢组学揭示了与胃食管腺癌进展相关的潜在生物标志物和代谢途径。
BMC Cancer. 2023 Dec 15;23(1):1238. doi: 10.1186/s12885-023-11744-y.
9
Tissue-based metabolomics reveals metabolic biomarkers and potential therapeutic targets for esophageal squamous cell carcinoma.基于组织的代谢组学揭示了食管鳞癌的代谢生物标志物和潜在治疗靶点。
J Pharm Biomed Anal. 2021 Apr 15;197:113937. doi: 10.1016/j.jpba.2021.113937. Epub 2021 Feb 5.
10
Secreted proteins encoded by super enhancer-driven genes could be promising biomarkers for early detection of esophageal squamous cell carcinoma.由超级增强子驱动基因编码的分泌蛋白可能是早期检测食管鳞状细胞癌的有前途的生物标志物。
Biomed J. 2024 Aug;47(4):100662. doi: 10.1016/j.bj.2023.100662. Epub 2023 Sep 27.

引用本文的文献

1
Applications and advances of multi-omics technologies in gastrointestinal tumors.多组学技术在胃肠道肿瘤中的应用与进展
Front Med (Lausanne). 2025 Jul 23;12:1630788. doi: 10.3389/fmed.2025.1630788. eCollection 2025.
2
Integrated single cell and bulk RNA sequencing analyses reveal the impact of tryptophan metabolism on prognosis and immunotherapy in colon cancer.整合单细胞和批量RNA测序分析揭示色氨酸代谢对结肠癌预后和免疫治疗的影响。
Sci Rep. 2025 Apr 11;15(1):12496. doi: 10.1038/s41598-025-85893-4.
3
Microbiota-Gut-Brain Axis: Mass-Spectrometry-Based Metabolomics in the Study of Microbiome Mediators-Stress Relationship.
微生物群-肠道-脑轴:基于质谱的代谢组学在微生物组介导因子与应激关系研究中的应用
Biomolecules. 2025 Feb 7;15(2):243. doi: 10.3390/biom15020243.
4
Latest insights into the global epidemiological features, screening, early diagnosis and prognosis prediction of esophageal squamous cell carcinoma.食管鳞状细胞癌全球流行病学特征、筛查、早期诊断及预后预测的最新研究进展。
World J Gastroenterol. 2024 May 28;30(20):2638-2656. doi: 10.3748/wjg.v30.i20.2638.
5
Construction and validation of serum Metabolic Risk Score for early warning of malignancy in esophagus.用于食管癌恶性肿瘤早期预警的血清代谢风险评分的构建与验证
iScience. 2024 May 11;27(6):109965. doi: 10.1016/j.isci.2024.109965. eCollection 2024 Jun 21.
6
NMR and MS reveal characteristic metabolome atlas and optimize esophageal squamous cell carcinoma early detection.NMR 和 MS 揭示了特征代谢组图谱,并优化了食管鳞状细胞癌的早期检测。
Nat Commun. 2024 Mar 19;15(1):2463. doi: 10.1038/s41467-024-46837-0.
7
Untargeted serum metabolomics reveals potential biomarkers and metabolic pathways associated with the progression of gastroesophageal cancer.非靶向血清代谢组学揭示了与胃食管腺癌进展相关的潜在生物标志物和代谢途径。
BMC Cancer. 2023 Dec 15;23(1):1238. doi: 10.1186/s12885-023-11744-y.
8
Small molecule metabolites: discovery of biomarkers and therapeutic targets.小分子代谢物:生物标志物和治疗靶点的发现。
Signal Transduct Target Ther. 2023 Mar 20;8(1):132. doi: 10.1038/s41392-023-01399-3.